این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
Cell Journal، جلد ۱۹، شماره ۱، صفحات ۱۲۷-۱۳۶
عنوان فارسی
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله
عنوان انگلیسی Inhibitory Effect of Mesenchymal Stem Cell Co-Culture on Erythroid Differentiation of K562 Cells Compared to The Control Group
چکیده انگلیسی مقاله Objective
Bone marrow mesenchymal stem cells (BMMSCs) reside in the bone marrow and control the process of hematopoiesis. They are an excellent instrument for regenerative treatment and co-culture with hematopoietic stem cells (HSCs).
Materials and Methods
In this experimental study, K562 cell lines were either treated with butyric acid and co-cultured with MSCs, or cultivated in a conditioned medium from MSCs plus butyric acid for erythroid differentiation. We used the trypan blue dye exclusion assay to determine cell counts and viability in each group. For each group, we separately assessed erythroid differentiation of the K562 cell line with Giemsa stain under light microscopy, expression of specific markers of erythroid cells by flowcytometry, and erythroidspecific gene expressions by real-time polymerase chain reaction (RT-PCR).
Results
There was enhandced erythroid differentiation of K562 cells with butyric acid compared to the K562 cell line co-cultured with MSCs and butyric acid. Erythroid differentiation of the K562 cell line cultivated in conditioned medium with butyric acid was higher than the K562 cell line co-cultured with MSCs and butyric acid, but less than K562 cell line treated with butyric acid only.
Conclusion
Our results showed that MSCs significantly suppressed erythropoiesis. Therefore, MSCs would not be a suitable optimal treatment strategy for patients with erythroid leukemia.
کلیدواژه‌های انگلیسی مقاله Mesenchymal stem cells, K562 cells, Erythroid Differentiation
نویسندگان مقاله Mahshid Saleh |
Hematology Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

Karim Shamsasanjan |
Hematology Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

Ali Akbari Movassaghpour |
Hematology Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

Parvin Akbarzadehlaleh |
Department of Pharmacutical Biotechnology, Tabriz University of Medical Sciences, Tabriz, Iran

Zahra Molaeipour |
Hematology Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

نشانی اینترنتی https://www.celljournal.org/article_250419_2d741a6e2876ad77195458469fe24a08.pdf
فایل مقاله فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات